Gregory B Lesinski

22PUBLICATIONS
115CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jul 06, 2026
TLR9 Agonists Potentiate Adoptive T Cell Therapy in Cancer through a B Cell-CD2 Costimulatory Axis.

|Jun 30, 2026
A randomized phase 2 study of combination atezolizumab and varlilumab (CDX-1127) with or without cobimetinib in previously-treated unresectable biliary tract cancer.

|Feb 25, 2026
Loss of miR-29a/b1 Cluster Reprograms the Tumor Microenvironment and Contributes to Immunosuppression in Lung Cancer.

Natalie K Horvat, Myritney Saint-Cloud, Raihaanah Bint Abdullah Muslim

|Dec 19, 2025
High-Dimensional Protein Analysis Uncovers Distinct Immunologic and Stromal Features in Primary and Metastatic Pancreatic Ductal Adenocarcinoma.

Emily Greene, Natalie K Horvat, Deon Bryant Doxie

|Dec 05, 2025
T-cell Priming by High-Avidity Neoantigens in Lymph Nodes Augments Adoptive Immunotherapy.

Megen C Wittling, Amalia M Rivera-Reyes, Megan M Wyatt

|Aug 25, 2025
Constructing the cure: engineering the next wave of antibody and cellular immune therapies.

Stefanie R Bailey, Eric Bartee, Kyle G Daniels

Pageof 4

Frequent Collaborators

10 joint publications

Chrystal M Paulos

5 joint publications

Megen C Wittling

5 joint publications

Guillermo O Rangel Rivera

5 joint publications

Anna C Cole